Oncimmune Holdings (GB:ONC) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Oncimmune Holdings, a leader in autoantibody profiling for precision medicine, has distributed a Circular to its shareholders outlining details of its upcoming General Meeting. This meeting, scheduled for November 8, 2024, is set to address resolutions for Fundraising and Debt Restructuring. The company’s initiative aims to bolster its financial health and enhance its collaborations in the pharmaceutical and biotech sectors.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.